Q Therapeutics, Inc.
Q Therapeutics, Inc. (Q Therapeutics) is a privately held biopharmaceutical company, engaged in utilizing cell-based technologies to develop new treatments for debilitating diseases of the central nervous system (CNS). The company has exclusive licenses with many institutions resulting in 16 issued patents. Further, it is focused on natural cell-based products that replace insulating myelin on damaged neurons to restore normal neuron function. Its lead product Q-Cells, is for the treamtnet of wide range of diseases, including multiple sclerosis (MS), transverse myelitis, cerebral palsy, spinal cord injury, and certain types of stroke. Q Therapeutics is headquartered at Salt Lake city, Utah, the US.